Entering text into the input field will update the search result below

IsoPlexis' (ISO) CEO Sean Mackay on Q4 2021 Results - Earnings Call Transcript

Mar. 02, 2022 1:37 PM ETIsoPlexis Corporation (ISO)
SA Transcripts profile picture
SA Transcripts

IsoPlexis Corporation (NASDAQ:ISO) Q4 2021 Earnings Conference Call March 2, 2022 8:30 AM ET

Company Participants

Carrie Mendivil – Investor Relations

Sean Mackay – Chief Executive Officer

John Strahley – Chief Financial Officer

Conference Call Participants

Max Masucci – Cowen and Company

Vijay Kumar – Evercore ISI

Puneet Souda – SVB Leerink


Good day. And welcome to the IsoPlexis’ Fourth Quarter 2021 Earnings Conference Call. [Operator Instructions] As a reminder this call may be recorded.

I would now like to turn the call over to Carrie Mendivil, Investor Relations. You may begin.

Carrie Mendivil

Thank you. Earlier today, IsoPlexis released financial results for the quarter and year ended December 31, 2021. If you have not received this news release or if you'd like to be added to the company's distribution list, please send an e-mail to investors@isoplexis.com.

Joining me today from IsoPlexis are Sean Mackay, Chief Executive Officer; and John Strahley, Chief Financial Officer.

Before we begin, I'd like to remind you that management will make statements during this call that are forward-looking statements within the meaning of federal securities laws. These statements involve material risks and uncertainties that could cause actual results or events to materially differ from those anticipated. Additional information regarding these risks and uncertainties appears in the section entitled Forward-Looking Statements in the press release IsoPlexis issued today. For a more complete list of description, please see the Risk Factors section of the company’s quarterly report in Form 10-Q filed on November 12, 2021, and the Company’s other filings with the Securities and Exchange Commission.

IsoPlexis intends to file its annual report on Form 10-K for the year ended December 31, 2021, next week. Except as required by law, IsoPlexis disclaims any intention or obligation to update or revise any financial projections or forward-looking statements, whether because of new information, future

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.